Molson Coors in Mid-2026; Still $2+ Bil in EBITDA; Losing Volume and Share; Green Shoots

Molson Coors reported another soft qtr in US with STRs down 6% (including gains from Monaco and Fever-Tree) and its profits under pressure, yet multiple analysts labeled it “better than feared.” MC maintained its guidance for full yr, which is for flat revs, plus or minus 1%, and profits down...
Read more...

Publishing Info

  • Year: 2026
  • Volume: 57
  • Issue #: 15
  • Issue Date: 08/14/2026